| 000 | 01628cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030234.0 | ||
| 008 | 100602s2010 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.12.M.Sc.2010.Ad.G | ||
| 100 | 0 | _aAdel Said Abdelghany Elantably | |
| 245 | 1 | 0 |
_aGene therapy in otorhinolaryngology / _cAdel Said Abdelghany Elantably ; Supervised Mohamed Nabil Lasheen , Mosaad Abdelaziz , Badawy Shafik Khalifa |
| 246 | 1 | 5 | _aالعلاج الجينى فى أمراض الأذن والأنف و الحنجرة |
| 260 |
_aCairo : _bAdel Said Abdelghany Elantably , _c2010 |
||
| 300 |
_a144 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of E.N.T | ||
| 520 | _aThe dramatic increases in the knowledge of the molecular and genetic basis of various diseases combined with advances in technology have resulted in novel molecular therapies for these diseases. Gene therapy, in utero or adults, which involves the transfer of genetic material to target cells via viral or non-viral vectors to produce a therapeutic effect | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aGene therapy | |
| 653 | 4 | _aUtero gene therapy | |
| 653 | 4 | _aVectors | |
| 700 | 0 |
_aBadawy Shafik Khalifa , _eSupervisor |
|
| 700 | 0 |
_aMohamed Nabil Lasheen , _eSupervisor |
|
| 700 | 0 |
_aMosaad Abdelaziz , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30519 _d30519 |
||